AVEFF Financials: Avecho Biotechnology Limited AI Analysis

Home

Stock

AVEFF

Financials

AVEFF Financial

Avecho Biotechnology Limited

At close: Mar 25, 16:00:00 GMT-4

Pre-market: Mar 26, 10:33:39 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$0.0045

Open

$0.0045

Day's Range

$0.003 - $0.0045

52 week range

$0.0014 - $0.0174

Volume

300.0K

Avg.Volume

Dividend yield

EPS (TTM)

0.00

Market Cap

$16.5M

What is AVECHO BIOTECHNOLOGY LTD?

Avecho Biotechnology Ltd. engages in the development and commercialization of human and animal products through its proprietary drug delivery system. The company is headquartered in Melbourne, Victoria. The firm develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The firm's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The firm's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The firm is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

AVEFF Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1	1	0	1	0	0
Revenue Growth (YoY)	0%	--	-100%	--	--	-100%
Cost of Revenue	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0
Selling, General & Admin	2	1	2	2	2	2
Research & Development	4	3	2	1	2	0
Operating Expenses	4	3	3	3	3	3
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-4	-3	-3	-2	-3	-2
Income Tax Expense	0	0	0	0	0	--
Net Income	-4	-3	-3	-2	-3	-2
Net Income Growth	33%	0%	50%	-33%	50%	--
Shares Outstanding (Diluted)	3,362.47	3,169.29	2,268.08	1,837.78	1,802.26	1,591.07
Shares Change (YoY)	6%	40%	23%	2%	13%	1%
EPS (Diluted)	0	0	0	0	0	0
EPS Growth	40%	-33%	15%	-32%	12%	-440%
Free Cash Flow	1	-3	-3	-1	-3	-1
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	0%	0%	0%	0%	0%	0%
Operating Margin	-300%	-300%	0%	-200%	0%	0%
Profit Margin	-400%	-300%	0%	-200%	0%	0%
Free Cash Flow Margin	100%	-300%	0%	-100%	0%	0%
EBITDA	-3	-3	-3	-2	-3	-2
EBITDA Margin	-300%	-300%	0%	-200%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-3	-3	-3	-2	-3	-2
EBIT Margin	-300%	-300%	0%	-200%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	--

Follow-Up Questions

What are Avecho Biotechnology Limited's key financial statements?



According to the latest financial statement (Form-10K), Avecho Biotechnology Limited has a total asset of $4, Net loss of $-3

What are the key financial ratios for AVEFF?



Avecho Biotechnology Limited's Current ratio is 4, has a Net margin is -300, sales per share of $0.

How is Avecho Biotechnology Limited's revenue broken down by segment or geography?



Avecho Biotechnology Limited largest revenue segment is Production, at a revenue of 1,132,672 in the most earnings release.For geography, Americas is the primary market for Avecho Biotechnology Limited, at a revenue of 708,540.

Is Avecho Biotechnology Limited profitable?



no, according to the latest financial statements, Avecho Biotechnology Limited has a net loss of $-3

Does Avecho Biotechnology Limited have any liabilities?



yes, Avecho Biotechnology Limited has liability of 1

How many outstanding shares for Avecho Biotechnology Limited?



Avecho Biotechnology Limited has a total outstanding shares of 3,169.29

Avecho Biotechnology Limited (AVEFF) Financial

AVEFF Stock Price Chart